NeuroOne Medical Technologies Corporation filed an updated Prospectus Supplement to offer and sell up to $13.4 million of common stock through an at-the-market offering program with JonesTrading Institutional Services LLC. The company is a developer of medical technology solutions for neurological and neurological-related disorders.
